HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lan Liao Selected Research

Steroid Receptors (Steroid Receptor)

8/2015Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.
3/2014Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
1/2014The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate.
7/2013The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.
1/2013Steroid receptor coactivator-1 mediates estrogenic actions to prevent body weight gain in female mice.
3/2011Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
9/2005Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
12/2002Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.
6/2002Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lan Liao Research Topics

Disease

30Neoplasms (Cancer)
01/2022 - 11/2002
14Neoplasm Metastasis (Metastasis)
01/2022 - 03/2004
11Breast Neoplasms (Breast Cancer)
09/2015 - 03/2004
9Carcinogenesis
01/2022 - 03/2004
6Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2015
4Body Weight (Weight, Body)
12/2019 - 08/2006
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 06/2007
3Type 2 Diabetes Mellitus (MODY)
11/2015 - 04/2004
2Infections
04/2021 - 01/2020
2Hyperplasia
12/2020 - 01/2014
2Obesity
12/2019 - 12/2016
2Insulin Resistance
04/2006 - 04/2004
2Diabetic Nephropathies (Diabetic Nephropathy)
12/2004 - 12/2003
2Diabetes Mellitus
08/2004 - 12/2003
1Oral Lichen Planus
10/2021
1Hypersensitivity (Allergy)
03/2021
1Colitis
03/2021
1Inflammation (Inflammations)
03/2021
1Hypoxia (Hypoxemia)
01/2021
1Hypopigmentation (Hypomelanosis)
01/2021
1Seizures (Absence Seizure)
01/2021
1Periodontitis
12/2020
1Peri-Implantitis
01/2020
1Bacterial Infections (Bacterial Infection)
01/2020
1Weight Loss (Weight Reduction)
12/2019
1Pain (Aches)
11/2019
1Adenocarcinoma
01/2019
1Fibrosis (Cirrhosis)
12/2018
1Cardiomegaly (Heart Hypertrophy)
12/2018
1Triple Negative Breast Neoplasms
08/2017
1Pathologic Processes
08/2017
1Colonic Neoplasms (Colon Cancer)
05/2016

Drug/Important Bio-Agent (IBA)

9Steroid Receptors (Steroid Receptor)IBA
08/2015 - 06/2002
8Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2003
6Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2017 - 11/2002
4Estrogen ReceptorsIBA
11/2011 - 10/2004
4Insulin-Like Growth Factor I (IGF-1)IBA
08/2011 - 03/2004
3Circular RNAIBA
01/2022 - 01/2018
3Small Interfering RNA (siRNA)IBA
01/2022 - 05/2016
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
3Androgen Receptors (Androgen Receptor)IBA
01/2019 - 06/2007
3Phenobarbital (Luminal)FDA Link
01/2019 - 01/2014
3Transcription Factors (Transcription Factor)IBA
08/2017 - 09/2005
3Hormones (Hormone)IBA
08/2017 - 03/2004
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
09/2015 - 03/2011
3Estrogens (Estrogen)FDA Link
03/2005 - 06/2002
2CateninsIBA
01/2022 - 01/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2021 - 04/2004
2Peptides (Polypeptides)IBA
01/2021 - 12/2019
2AndrogensIBA
01/2019 - 07/2013
2Lysine (L-Lysine)FDA Link
12/2018 - 11/2015
2Histones (Histone)IBA
12/2018 - 11/2015
2Histone DemethylasesIBA
12/2018 - 10/2017
2Serine (L-Serine)FDA Link
05/2016 - 06/2011
2Twist-Related Protein 1IBA
05/2016 - 06/2011
2Basic Helix-Loop-Helix Transcription FactorsIBA
05/2016 - 06/2011
2Insulin (Novolin)FDA Link
11/2015 - 04/2006
2Biological ProductsIBA
10/2015 - 12/2002
2Macrophage Colony-Stimulating FactorIBA
09/2015 - 01/2009
2MicroRNAs (MicroRNA)IBA
03/2015 - 02/2014
2Tumor Viral Antigens (Large T Antigen)IBA
01/2009 - 10/2004
2PPAR gammaIBA
10/2004 - 11/2002
2Blood Glucose (Blood Sugar)IBA
08/2004 - 12/2003
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2004 - 12/2003
1RNA (Ribonucleic Acid)IBA
01/2022
1LuciferasesIBA
01/2022
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
10/2021
1AntigensIBA
04/2021
1Glutens (Glutelin)IBA
03/2021
1SolventsIBA
03/2021
1Dextran SulfateIBA
03/2021
1Odorant Receptors (Odorant Receptor)IBA
03/2021
1Volatile Fatty AcidsIBA
03/2021
1Polysaccharides (Glycans)IBA
03/2021
1InterleukinsIBA
03/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2021
1Phenylalanine (L-Phenylalanine)FDA Link
01/2021
1CollagenIBA
12/2020
1SilverIBA
01/2020
1poly(lactide) (polylactic acid)IBA
01/2020
1Dental Implants (Dental Implant)IBA
01/2020
1Appetite Depressants (Anorectics)IBA
12/2019
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
12/2019
1LeptinIBA
12/2019
1HydrogelsIBA
11/2019
1Anesthetics (Anesthetic Agents)IBA
11/2019
1JIB-04IBA
12/2018
1Cyclin D1IBA
10/2017
1LigandsIBA
08/2017
1Member 1 Group A Nuclear Receptor Subfamily 4IBA
08/2017
1TeaIBA
12/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2016
1Long Noncoding RNAIBA
05/2016

Therapy/Procedure

4Therapeutics
08/2017 - 10/2013
3Castration
01/2019 - 07/2013
2Drug Therapy (Chemotherapy)
01/2021 - 10/2013
1Immunotherapy
01/2021
1Guided Tissue Regeneration
12/2020
1Local Anesthesia
11/2019
1Anesthesia
11/2019